The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients 论文

2016Science Translational Medicine引用 415
DOI
Alzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesComputational Drug Discovery Methods
Computational Drug Discovery MethodsCholinesterase and Neurodegenerative DiseasesAlzheimer's disease research and treatments
相关技术:Computational Drug Discovery MethodsCholinesterase and Neurodegenerative Diseases
关系图谱

The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients · 相关技术

相关技术

Computational Drug Discovery MethodsCholinesterase and Neurodegenerative Diseases